Molecular Cell, Год журнала: 2024, Номер 84(19), С. 3596 - 3609
Опубликована: Окт. 1, 2024
Язык: Английский
Molecular Cell, Год журнала: 2024, Номер 84(19), С. 3596 - 3609
Опубликована: Окт. 1, 2024
Язык: Английский
Molecular Cell, Год журнала: 2023, Номер 84(1), С. 107 - 119
Опубликована: Дек. 19, 2023
Язык: Английский
Процитировано
33Trends in Cell Biology, Год журнала: 2024, Номер unknown
Опубликована: Июль 1, 2024
Adenosine deaminase acting on RNA 1 (ADAR1) converts adenosine to inosine in double-stranded (dsRNA) molecules, a process known as A-to-I editing. ADAR1 deficiency humans and mice results profound inflammatory diseases characterised by the spontaneous induction of innate immunity. In cells lacking ADAR1, unedited RNAs activate sensors. These include melanoma differentiation-associated gene 5 (MDA5) that induces expression cytokines, particularly type I interferons (IFNs), protein kinase R (PKR), oligoadenylate synthase (OAS), Z-DNA/RNA binding (ZBP1). Immunogenic 'defused' may transcripts from repetitive elements other long duplex RNAs. Here, we review these recent fundamental discoveries discuss implications for human diseases. Some tumours depend escape immune surveillance, opening possibility unleashing anticancer therapies with inhibitors.
Язык: Английский
Процитировано
11RNA, Год журнала: 2024, Номер 30(5), С. 500 - 511
Опубликована: Март 26, 2024
Innate immunity must be tightly regulated to enable sensitive pathogen detection while averting autoimmunity triggered by pathogen-like host molecules. A hallmark of viral infection, double-stranded RNAs (dsRNAs) are also abundantly encoded in mammalian genomes, necessitating surveillance mechanisms distinguish “self” from “nonself.” ADAR1, an RNA editing enzyme, has emerged as essential safeguard against dsRNA-induced autoimmunity. By converting adenosines inosines (A-to-I) long dsRNAs, ADAR1 covalently marks endogenous thereby blocking the activation cytoplasmic dsRNA sensor MDA5. Moreover, beyond its function, binding impedes innate immune sensors PKR and ZBP1. Recent landmark studies underscore utility silencing for cancer immunotherapy, exploiting ADAR1-dependence developed certain tumors unleash antitumor response. In this perspective, we summarize genetic mechanistic evidence ADAR1's multipronged role suppressing dsRNA-mediated explore evolving roles immuno-oncology target.
Язык: Английский
Процитировано
8CNS Neuroscience & Therapeutics, Год журнала: 2025, Номер 31(1)
Опубликована: Янв. 1, 2025
ABSTRACT Background Adenosine deaminase action on RNA 1 (ADAR1) can convert the adenosine in double‐stranded (dsRNA) molecules into inosine a process known as A‐to‐I editing. ADAR1 regulates gene expression output by interacting with and other proteins; plays important roles development, including growth; is linked to innate immunity, tumors, central nervous system (CNS) diseases. Results In recent years, role of tumors has been widely discussed, but its CNS diseases not reviewed. It worth noting that studies have shown great potential treatment neurodegenerative diseases, mechanisms are still unclear. Therefore, it necessary elaborate Conclusions Here, we focus effects such Aicardi–AicardiGoutières syndrome, Alzheimer's disease, Parkinson's glioblastoma, epilepsy, amyotrophic lateral sclerosis, autism. We also evaluate impact ADAR1‐based strategies these particular development new technologies microRNAs, nanotechnology, editing, stem cell therapy. hope provide directions insights for future editing technology brain science
Язык: Английский
Процитировано
1iScience, Год журнала: 2025, Номер 28(3), С. 111950 - 111950
Опубликована: Фев. 4, 2025
Adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) are enzymes in the salvage pathway, which recycles purines to meet cellular demands. Mutations of these humans cause inflammatory immunodeficiency syndromes, but mechanisms not well understood. Prior work nematode Caenorhabditis elegans demonstrated that loss PNP ortholog PNP-1 induced an immune response called intracellular pathogen (IPR). Here, we show enzyme upstream ADAH-1 (ADA homolog) also induces IPR promotes resistance against pathogens. Unlike PNP-1, is essential for organismal development. Importantly, find supplementation deoxyadenosine, a substrate ADA, pathogens C. elegans, finding extend human cells. Thus, mutations ADA induce innate immunity through increased phenomenon conserved from humans.
Язык: Английский
Процитировано
1Current Opinion in Genetics & Development, Год журнала: 2024, Номер 86, С. 102195 - 102195
Опубликована: Апрель 21, 2024
Язык: Английский
Процитировано
7Methods in enzymology on CD-ROM/Methods in enzymology, Год журнала: 2025, Номер unknown, С. 153 - 185
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown
Опубликована: Янв. 28, 2025
Abstract Among the hundreds of modified nucleosides identified in terrestrial life, 2-amino-6-aminopurine (Z) is widely recognized as a prominent purine. Recently, RNA written with ZUGC alphabet shows significant potential therapeutics synthetic biosystem. Here, we demonstrate that ZUGC-RNA can evade immune recognition eukaryotes, independent factors such length, sequence, 5’-triphosphate, uridine, and secondary structure. Notably, discovered both degradation metabolites Z-nucleotides function immunosuppressors, silencing TLR7 sensing to block responses. This mechanism differs from pseudo-uridine (Ψ) currently use. ZUGC-RNAs also broad applicability across multiple neural cell types. Our findings provide valuable insights for developing more tolerable RNA-based drugs designing immunomodulators targeting TLR7. In addition prebiotic relevance Z, our finding not only contributes understanding world hypothesis but provides new into exploration origin life.
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Март 24, 2025
Язык: Английский
Процитировано
0PLoS Pathogens, Год журнала: 2025, Номер 21(4), С. e1012452 - e1012452
Опубликована: Апрель 8, 2025
Adenosine deaminase acting on dsRNA 1 (ADAR1) catalyzes the deamination of adenosines to inosines in double-stranded RNAs (dsRNA) and regulates innate immunity by preventing hyperactivation cytosolic sensors such as MDA5, PKR or ZBP1. ADAR1 has been shown exert pro- antiviral, editing-dependent editing-independent functions viral infections, but little is known about its function herpesvirus replication. We now demonstrate that herpes simplex virus (HSV-1) hyperactivates absence ADAR1, resulting eIF2α mediated translational arrest reduced Silencing inhibition downstream effectors (ICP34.5) pharmacological (ISRIB) inhibitors rescues replication ADAR1-deficient cells. Upon infection, p150 interacts with prevents hyperactivation. Our findings an important proviral factor raises activation threshold for immunity.
Язык: Английский
Процитировано
0